Non-genomic events determining the sensitivity of hemopoietic malignancies to glucocorticoid-induced apoptosis

Cancer Immunology, Immunotherapy

Volumn 63, Issue 1, 2014, Pages 37-43

  Kfir Erenfeld, Shlomit ^a   Yefenof, Eitan ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

BIM; CITIM 2013; Glucocorticoids; Glycogen synthase kinase 3; Hemopoietic tumors; Mitochondria

Indexed keywords

BECLIN 1; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; PREDNISONE; STAUROSPORINE; WORTMANNIN;

APOPTOSIS; CELL FATE; CELL SURVIVAL; CYTOSOL; DRUG RESISTANCE; DRUG SENSITIVITY; HORMONAL THERAPY; HUMAN; LEUKEMIA; LYMPHOID CELL; LYMPHOMA; MITOCHONDRION; PRIORITY JOURNAL; REVIEW;

EID: 84891880086     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-013-1477-8     Document Type: Review

References (45)

1. Zhang G, Zhang L, Duff GW (1997) A negative regulatory region containing a glucocorticosteroid response element (nGRE) in the human interleukin-1beta gene. DNA Cell Biol 16(2):145-152 (Pubitemid 27104563)
2. Dostert A, Heinzel T (2004) Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr Pharm Des 10(23):2807-2816 (Pubitemid 39162399)
3. Kfir-Erenfeld S, Sionov RV, Spokoini R, Cohen O, Yefenof E (2010) Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations. Leuk Lymphoma 51(11):1968-2005. doi: 10.3109/10428194.2010.506570
4. Sionov RV, Spokoini R, Kfir-Erenfeld S, Cohen O, Yefenof E (2008) Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis. Adv Cancer Res 101:127-248. doi: 10.1016/S0065-230X(08)00406-5
5. Pratt WB, Toft DO (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18(3):306-360 (Pubitemid 27246880)
6. Sionov RV, Cohen O, Kfir S, Zilberman Y, Yefenof E (2006) Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis. J Exp Med 203(1):189-201. doi: 10.1084/jem.20050433 (Pubitemid 43139657)
7. Talaber G, Boldizsar F, Bartis D, Palinkas L, Szabo M, Berta G, Setalo G Jr, Nemeth P, Berki T (2009) Mitochondrial translocation of the glucocorticoid receptor in double-positive thymocytes correlates with their sensitivity to glucocorticoid-induced apoptosis. Int Immunol 21(11):1269-1276. doi: 10.1093/intimm/dxp093
8. Kfir S, Sionov RV, Zafrir E, Zilberman Y, Yefenof E (2007) Staurosporine sensitizes T lymphoma cells to glucocorticoid-induced apoptosis: role of Nur77 and Bcl-2. Cell Cycle 6(24):3086-3096
9. Spokoini R, Kfir-Erenfeld S, Yefenof E, Sionov RV (2010) Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis. Mol Endocrinol 24(6):1136-1150. doi: 10.1210/me.2009-0466
10. Wang Z, Malone MH, He H, McColl KS, Distelhorst CW (2003) Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem 278(26):23861-23867. doi: 10.1074/jbc.M301843200 (Pubitemid 36830212)
11. Zhang L, Insel PA (2004) The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells. J Biol Chem 279(20):20858-20865. doi: 10.1074/jbc.M310643200 (Pubitemid 38656482)
12. Bouillet P, Zhang LC, Huang DC, Webb GC, Bottema CD, Shore P, Eyre HJ, Sutherland GR, Adams JM (2001) Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm Genome 12(2):163-168 (Pubitemid 32147673)
13. Gilley J, Coffer PJ, Ham J (2003) FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 162(4):613-622. doi: 10.1083/jcb.200303026 (Pubitemid 37022939)
14. Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, Burgering BM, Medema RH (2002) The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol 168(10):5024-5031 (Pubitemid 34495965)
15. Ma J, Xie Y, Shi Y, Qin W, Zhao B, Jin Y (2008) Glucocorticoid-induced apoptosis requires FOXO3A activity. Biochem Biophys Res Commun 377(3):894-898. doi: 10.1016/j.bbrc.2008.10.097
16. Urbich C, Knau A, Fichtlscherer S, Walter DH, Bruhl T, Potente M, Hofmann WK, de Vos S, Zeiher AM, Dimmeler S (2005) FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J 19(8):974-976. doi: 10.1096/fj.04-2727fje (Pubitemid 40827722)
17. Abrams MT, Robertson NM, Yoon K, Wickstrom E (2004) Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA. J Biol Chem 279(53):55809-55817. doi: 10.1074/jbc.M411767200 (Pubitemid 40066588)
18. Lu J, Quearry B, Harada H (2006) p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells. FEBS Lett 580(14):3539-3544. doi: 10.1016/j.febslet.2006.05.031 (Pubitemid 44208999)
19. O'Reilly LA, Cullen L, Visvader J, Lindeman GJ, Print C, Bath ML, Huang DC, Strasser A (2000) The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells. Am J Pathol 157(2):449-461. doi: 10.1016/S0002-9440(10)64557-9 (Pubitemid 30626908)
20. Puthalakath H, Strasser A (2002) Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 9(5):505-512. doi: 10.1038/sj/cdd/4400998 (Pubitemid 34521178)
21. Lomonosova E, Chinnadurai G (2008) BH3-only proteins in apoptosis and beyond: an overview. Oncogene 27(Suppl 1):S2-S19. doi: 10.1038/onc.2009.39
22. Rathmell JC, Lindsten T, Zong WX, Cinalli RM, Thompson CB (2002) Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol 3(10):932-939. doi: 10.1038/ni834 (Pubitemid 35154006)
23. Rambal AA, Panaguiton ZL, Kramer L, Grant S, Harada H (2009) MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM. Leukemia 23(10):1744-1754. doi: 10.1038/leu.2009.80
24. Laane E, Panaretakis T, Pokrovskaja K, Buentke E, Corcoran M, Soderhall S, Heyman M, Mazur J, Zhivotovsky B, Porwit A, Grander D (2007) Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members. Haematologica 92(11):1460-1469. doi: 10.3324/haematol.10543 (Pubitemid 350144120)
25. Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, Laessig TA, Bouchard RJ, Florez-McClure ML, Heidenreich KA (2004) Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 24(44):9993-10002. doi: 10.1523/JNEUROSCI.2057-04.2004 (Pubitemid 39463581)
26. Pastorino JG, Hoek JB, Shulga N (2005) Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res 65(22):10545-10554. doi: 10.1158/0008-5472.CAN-05-1925 (Pubitemid 41743749)
27. Sade H, Khandre NS, Mathew MK, Sarin A (2004) The mitochondrial phase of the glucocorticoid-induced apoptotic response in thymocytes comprises sequential activation of adenine nucleotide transporter (ANT)-independent and ANT-dependent events. Eur J Immunol 34(1):119-125. doi: 10.1002/eji.200324650 (Pubitemid 38111527)
28. Pastorino JG, Shulga N, Hoek JB (2002) Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 277(9):7610-7618. doi: 10.1074/jbc.M109950200 (Pubitemid 34953160)
29. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378(6559):785-789. doi: 10.1038/378785a0 (Pubitemid 26004411)
30. Beurel E, Jope RS (2006) The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol 79(4):173-189. doi: 10.1016/j.pneurobio.2006.07.006 (Pubitemid 44331500)
31. Nuutinen U, Postila V, Matto M, Eeva J, Ropponen A, Eray M, Riikonen P, Pelkonen J (2006) Inhibition of PI3-kinase-Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell line. Exp Cell Res 312(3):322-330. doi: 10.1016/j.yexcr.2005.10.023 (Pubitemid 41814841)
32. Ogawa M, Nishiura T, Oritani K, Yoshida H, Yoshimura M, Okajima Y, Ishikawa J, Hashimoto K, Matsumura I, Tomiyama Y, Matsuzawa Y (2000) Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line. Cancer Res 60(15):4262-4269 (Pubitemid 30636615)
33. Sade H, Sarin A (2003) IL-7 inhibits dexamethasone-induced apoptosis via Akt/PKB in mature, peripheral T cells. Eur J Immunol 33(4):913-919. doi: 10.1002/eji.200323782 (Pubitemid 36546679)
34. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96(6):857-868 (Pubitemid 29165088)
35. Pekarsky Y, Hallas C, Palamarchuk A, Koval A, Bullrich F, Hirata Y, Bichi R, Letofsky J, Croce CM (2001) Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc Natl Acad Sci USA 98(7):3690-3694. doi: 10.1073/pnas.051003198 (Pubitemid 32249832)
36. Mittelstadt PR, DeFranco AL (1993) Induction of early response genes by cross-linking membrane Ig on B lymphocytes. J Immunol 150(11):4822-4832 (Pubitemid 23150349)
37. Liu ZG, Smith SW, McLaughlin KA, Schwartz LM, Osborne BA (1994) Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367(6460):281-284. doi: 10.1038/367281a0 (Pubitemid 24051145)
38. Woronicz JD, Calnan B, Ngo V, Winoto A (1994) Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367(6460):277-281. doi: 10.1038/367277a0 (Pubitemid 24051144)
39. Winoto A, Littman DR (2002) Nuclear hormone receptors in T lymphocytes. Cell 109(Suppl):S57-S66 (Pubitemid 34457852)
40. Lin B, Kolluri SK, Lin F, Liu W, Han YH, Cao X, Dawson MI, Reed JC, Zhang XK (2004) Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116(4):527-540 (Pubitemid 38264430)
41. Li QX, Ke N, Sundaram R, Wong-Staal F (2006) NR4A1, 2, 3 an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. Histol Histopathol 21(5):533-540
42. Rajpal A, Cho YA, Yelent B, Koza-Taylor PH, Li D, Chen E, Whang M, Kang C, Turi TG, Winoto A (2003) Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor. EMBO J 22(24):6526-6536. doi: 10.1093/emboj/cdg620 (Pubitemid 38009600)
43. Masuyama N, Oishi K, Mori Y, Ueno T, Takahama Y, Gotoh Y (2001) Akt inhibits the orphan nuclear receptor Nur77 and T-cell apoptosis. J Biol Chem 276(35):32799-32805. doi: 10.1074/jbc.M105431200
44. Chen HZ, Zhao BX, Zhao WX, Li L, Zhang B, Wu Q (2008) Akt phosphorylates the TR3 orphan receptor and blocks its targeting to the mitochondria. Carcinogenesis 29(11):2078-2088. doi: 10.1093/carcin/bgn197
45. Sionov RV, Kfir S, Zafrir E, Cohen O, Zilberman Y, Yefenof E (2006) Glucocorticoid-induced apoptosis revisited: a novel role for glucocorticoid receptor translocation to the mitochondria. Cell Cycle 5(10):1017-1026 (Pubitemid 43778733)